Editor’s Note: Expanded Biopharma Coverage Coming Soon
Executive Summary
Scrip is expanding the breadth and global reach of our content for members of the global biopharma commercial community.
Starting on July 11, Scrip, PharmAsia News and Start-Up will be amalgamated to bring readers of all three publications more in-depth insights into commercial developments in the global biopharma market. The new service will retain the Scrip name and all current subscribers to one or more of the three brands will have immediate access to it.
This full content stream will be on the new platform that we launched in April. By joining forces we are enhancing an outstanding business intelligence service, drawing on hundreds of years of cumulative experience by our international team of journalists who will continue reporting on the issues that affect readers all around the world.
You will continue to receive the insightful analysis and in-depth coverage that readers of each product rely upon. But now, you will get it all in one place.
There will be additional information and instructions on the launch day, Monday, July 11. Online and PDF readers of this notice can also click to read our fact sheet.